Atlas Venture - We build breakthrough biotechnology companies.

Creating and building breakthrough biotechs for over 30 years

Partnering with the world's best life science entrepreneurs

Translating groundbreaking science into life-changing medicines

Scroll to explore

FDA approves Replimune melanoma drug previously rejected twice

Less than year after launch, Caldera lines up $278M financing and Nasdaq debut

Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal

Thirty years at the leading-edge of medical innovation and we’re just getting started.